In this week’s Healthtech of the Week, we return to topics from the FemTech category. OvuFriend, a Polish platform in this space, has become an innovative support system for women at every stage of their reproductive lives: from the first period, through trying to conceive and pregnancy, all the way to perimenopause. Thanks to AI algorithms, the app not only helps increase the chances of getting pregnant but also enables early detection of hormonal and gynecological disorders.

 

As the founders admit, the impulse to create OvuFriend came from conversations with women who, often in a sense of loneliness, struggled with recurring challenges: uncertainty about ovulation timing, lack of reliable data-driven guidance, and limited access to personalized support. The first version of the app was designed as an intelligent assistant for those trying to conceive, analyzing individual cycles and identifying fertility signals.

Today, OvuFriend serves as a digital guide to reproductive health, supporting women in monitoring their menstrual cycles, pregnancies, and perimenopausal stages. The platform integrates medical knowledge, data analysis, and psychological aspects, giving users a sense of control and trust.

Press Release

Trust as a Foundation

In such a sensitive area as reproductive health, the reliability of technology is crucial. OvuFriend’s effectiveness has been confirmed in scientific research projects conducted in collaboration with the National Centre for Research and Development. The platform applies the highest standards of data security, as all information is encrypted and full control remains with the user.

OvuFriend is not just an app. It is the largest online community in Poland for women taking care of their hormonal and reproductive health. The forum already includes over 10 million posts, with around 300,000 women using it monthly. It’s a space where women can anonymously share experiences, receive emotional support, and get practical advice – says Joanna Fedorowicz, CEO and co-founder of the project.

Regular cycle monitoring in OvuFriend makes it possible to catch early signs of potential disorders such as polycystic ovary syndrome (PCOS), thyroid diseases, hyperprolactinemia, luteal phase defects, anovulation, or abnormal cycle lengths.

Often, it is the app that first signals the need for a medical consultation before symptoms become more severe. This shortens the diagnostic process and allows earlier treatment interventions.

 

Collaboration with Doctors and Data Integration

The app also simplifies diagnostic work for doctors. During an appointment, patients can present comprehensive reports from the app, such as cycle charts, symptoms in relation to menstrual phases, notes, and test results. This documentation allows for faster and more accurate analysis. Additionally, the platform collaborates with clinics and specialists, offering users recommendations of trusted facilities as well as discounts on tests and consultations.

OvuFriend is evolving toward comprehensive hormonal health diagnostics and currently operates in four modes: menstrual cycle tracking, trying to conceive, pregnancy, and perimenopause—a module dedicated to women 40+, helping recognize and ease the symptoms of this often misunderstood stage of life.

According to its creators, as part of the research and development project OvuFriend 2.0, co-financed by EU funds, an AI system was developed capable of early detection of hormonal and anatomical disorders, including thyroid diseases, PCOS, hyperprolactinemia, and luteal phase defects. The innovative Health Assistant supports users by intelligently asking for missing data, improving both convenience and analysis quality.

Press release

How Does AI Work in OvuFriend?

OvuFriend’s algorithms analyze over 80 parameters, including cervical mucus symptoms, ovulation tests, cyclic ailments such as spotting or pain, body temperature, mood and well-being, lifestyle factors, and even symptoms seemingly unrelated to fertility, such as dry skin or hair loss. The system learns from both individual and collective data, covering millions of anonymous cycles, which enables personalized predictions and precise adaptation to irregular cycles, including those of women with PCOS.

– One of the most common comments from users is their surprise at discovering ovulation shifts, for example, on day 11 of the cycle instead of the standard day 14 – notes the OvuFriend CEO.

The biggest challenge in integrating AI with medicine is balancing automation with individual care. OvuFriend emphasizes that the app never replaces doctors, as only specialists can provide diagnoses. AI plays a supportive role, providing doctors and patients with valuable data and early warning signals.

Another significant challenge is data quality. The OvuFriend team continuously monitors and updates algorithms, adapting them to new populations and clinical study results. The app’s mechanisms encourage users to log data regularly in an intuitive way, ensuring the most accurate analysis without overburdening them.

 

The Future of Digital Reproductive Medicine

OvuFriend exemplifies how medical technologies and artificial intelligence can genuinely improve women’s health. It not only supports the path to pregnancy but also enables prevention and early diagnosis of hormonal disorders.

At a time when knowledge about women’s health is still often fragmented and access to specialists limited, such solutions are invaluable. We will certainly be trying out the app—and are already keeping our fingers crossed for its continued growth!

Stay tuned for more in the “HealthTech of the Week” series, where we’ll continue to uncover fascinating stories from the world of medical technologies that are changing the face of healthcare. If you’re working on an innovative project in the field of new technologies and medicine or want to recommend an interesting solution, contact us at: [email protected].